Sana Biotechnology Inc expected to post a loss of 45 cents a share - Earnings Preview

Sana Biotechnology

27/10/2023 15:42

* Sana Biotechnology Inc  SANA.OQ   SANA.O  is expected
to show no
change in quarterly revenue when it reports  results 
    * 
    * ​Refinitiv's mean analyst estimate for Sana Biotechnology
Inc is
for a loss of 45 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sana
Biotechnology Inc is $9.5​, above​ its last closing price
of $2.92. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.42       -0.43      -0.59     Missed  -38.3
 Mar. 31 2023  -0.42       -0.45      -0.43     Beat    3.7
 Dec. 31 2022  -0.51       -0.51      -0.38     Beat    26.2​
 Sep. 30 2022  -0.53       -0.53      -0.45     Beat    15.1
 ​​Jun.        -0.51       -0.51      -0.39     Beat    23
 30 2022                                                
 Mar. 31 2022  -0.47       -0.47      -0.47     Met     0.7​
 Dec. 31 2021              -0.55      -0.60     Missed  -8.1
 Sep. 30 2021  -0.46       -0.49      -0.46     Beat    6.8
 This summary was machine generated October 27 at 14:42 GMT.  All
figures in US dollars  unless otherwise stated